Questcor to Present at Upcoming Investor Conferences.UNION CITY, Calif. -- James L. Fares, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Questcor Pharmaceuticals, Inc. (AMEX AMEX See: American Stock Exchange :QSC QSC Quality Service Communications (Cologne, Germany) QSC Quilter Sound Company (QSC Audio Products Inc.) QSC Queens Surface Corporation QSC Low-Traffic Ship (radiotelegraphy) ), will give a presentation at the Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services, Conference on September 6-7, 2006 at the Westin Times Square in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Mr. Fares will be presenting on Wednesday, September 6 at 3:30 pm Eastern Time (12:30 pm Pacific Time). The presentation will be webcast and is accessible live and archived via the following link, http://www.wsw.com/webcast/roth8/qsc/. Mr. Fares will also be presenting at the ThinkEquity Partners 4th Annual Growth Conference on September 12-13, 2006 at The Ritz Carlton Hotel in San Francisco. Mr. Fares will be presenting on Wednesday, September 13 at 11:00 am Eastern Time (8:00 am Pacific Time). The presentation will be webcast and is accessible live and archived via the following link, http://www.wsw.com/webcast/tep10/qsc/. Both presentations may be accessed on Questcor's website, www.questcor.com, following each event for a period of up to two weeks. About Questcor -- Questcor Pharmaceuticals, Inc.(R) (AMEX:QSC) is a specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurological disorders. Questcor currently markets H.P. Acthar(R) Gel (repository corticotropin corticotropin (kôr'təkōtrōp`ən): see adrenocorticotropic hormone. injection), an injectable drug indicated for the treatment of exacerbations associated with multiple sclerosis and Doral(R) (quazepam) that is indicated for the treatment of insomnia, characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. For more information, please visit www.questcor.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion